Selective immunosuppressants

265 Pill - purple capsule-shape, 18mm

Pill with imprint 265 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Ascend Laboratories LLC.

Mycophenolate mofetil is used in the treatment of Nephrotic Syndrome; Organ Transplant, Rejection Prophylaxis; Graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Mycophenolate mofetil (oral/injection) (Mycophenolate mofetil (oral/injection) [ mye-koe-fen-oh-late-moe-fe-til ])-265-500 mg-Purple-Capsule-shape
Mycophenolate mofetil (oral/injection) (Mycophenolate mofetil (oral/injection) [ mye-koe-fen-oh-late-moe-fe-til ])-265-500 mg-Purple-Capsule-shape

Mycophenolate mofetil (oral/injection)
Generic Name: mycophenolate mofetil (oral/injection) [ mye-koe-fen-oh-late-moe-fe-til ]
Imprint: 265
Strength: 500 mg
Color: Purple
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Selective immunosuppressants
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 67877-0225
Inactive Ingredients: Croscarmellose sodium, Magnesium stearate, Povidone, Microcrystalline cellulose, Hypromelloses, Polyethylene glycol, Isopropyl alcohol, Titanium dioxide, Ferric oxide red, Ferrosoferric oxide,
Latest News
Related Drugs